Indole-3-carbinol

DRUG6 trials

Sponsors

University of Kansas Medical Center, University of Kansas, Vanderbilt University, University of Wisconsin, Madison, Masonic Cancer Center, University of Minnesota

Conditions

Breast CancerEndometriosisObesityProstate CancerSmokingUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer

CompletedNCT00033345

University of Kansas Medical CenterBreast Cancer

Start: 2002-01-31Updated: 2016-08-18

Indole-3-Carbinol in Preventing Cancer in Healthy Participants

CompletedNCT00100958

University of KansasUnspecified Adult Solid Tumor, Protocol Specific

Start: 2004-11-30Updated: 2008-07-24

Trial of Indole-3-Carbinol and Silibinin

CompletedNCT03687073

Masonic Cancer Center, University of MinnesotaSmoking

Start: 2018-11-29End: 2021-05-07Updated: 2021-08-11

Phase 2

Indole-3-Carbinol Effects on Estrogen Metabolism

TerminatedNCT00988845

University of Wisconsin, MadisonObesity

Start: 2009-09-30End: 2014-01-31Updated: 2019-12-13

Phase 3

Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis

RecruitingNCT07164183

AlceaEndometriosis

Start: 2025-09-11End: 2026-11-30Target: 290Updated: 2025-09-18

Unknown Phase

Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate Cancer

CompletedNCT00607932

Vanderbilt UniversityProstate Cancer

Start: 2005-03-31End: 2010-11-30Target: 66Updated: 2016-04-27